Baseline characteristics

n

%

Mean ± SD

95% CI

Median

Age (years)

300

63.4 ± 9.0

62.4 - 64.4

64.0

Men

169

56.3

Women

131

43.7

Body weight (kg)

300

96.1 ± 17.6

93.1 - 98.1

95.0

BMI (kg/m2)

299

32.7 ± 5.4

32.1 - 33.3

31.8.

Systolic BP (mm Hg)

300

137.3 ± 15.1

135.6 - 139.0

136.0

Diastolic BP (mm Hg)

300

74.0 ± 9.5

77.9 - 80.1

80.0

HbA1c (mmol/mol)

300

72.4 ± 10.3

71.2 - 73.5

69.5

HbA1c (% DCCT)

300

8.8 ± 0.9

8.7 - 8.9

8.5

FPG (mmol/L)

300

9.3 ± 2.8

8.9 - 9.6

8.9

Creatinine (µmol/L)

265

84.6 ± 21.6

NA

83.0

Duration of diabetes

<5 years

65

22

5 - 10 years

79

26

>10 years

156

52

Initial dose of insulin glargine 300 U/mL

300

27.1 ± 12.2

25.7 - 28.5

24.0

OAD treatment

metformin

249

83

sulfonylurea

129

43

pioglitazone

13

4

DPP-4 inhibitors

102

34

glinides

9

3

α-glucosidase inhibitors

297

99

SGLT2 inhibitors

37

12

GLP1 receptor agonists

21

7